q2K BHP
Black History Portal
THE BHP WIRE —
HIDDEN TRUTHS
What's New!
THE JOURNEY THROUGH TIME

Explore Black History

Explore the people, places, events, achievements, struggles and stories that shaped our journey.

✊🏾

Civil Rights

Movements, leaders, victories and the continuing fight for equality.

⚙️

Black Inventors

Innovation, patents, science, technology and world-changing contributions.

🏆

Sports

Pioneers, champions, Negro Leagues, records, activism and excellence.

♟️

People

Meet the people whose lives, choices and achievements shaped the journey.

📍

Places

Black towns, communities, institutions and places where history happened.

📜

Events

Moments that changed communities, movements, institutions and the nation.

Enter a person, place, event, or topic.
MY'STORY

The MOVE Fire

This is a personal recollection on the Move fire on May 13, 1985 Philadelphia police fired thousands of rounds at the MOVE house, city officials approved dropping an explosive device on the roof, the resulting fire was allowed to burn, 11 people—including five children—died, and 61 homes were destroyed. Philadelphia City Council later called it a “brutal attack carried out by the City of Philadelphia on its own citizens” and acknowledged that no individual faced criminal consequences for the bombing. One timeline correction worth preserving for the BHP record: the major previous MOVE-police confrontation was August 8, 1978, about seven years before the bombing, not a year or two earlier. Officer James Ramp was killed, other police and firefighters were wounded, nine MOVE members were later convicted, and television cameras recorded police beating Delbert Africa during his arrest. The 1985 MOVE Commission later specifically criticized city planners for failing to adequately use lessons from that 1978 confrontation. And that actually strengthens the point you’re making: 1985 did not happen without precedent or institutional memory. There had already been a deadly confrontation with MOVE, years of conflict, negotiations and police involvement before Osage Avenue.

MORE →
BLACK FACTS
The Truths They Never Taught You...

Shirley Chisholm — Unbought and Unbossed

In 1968 Shirley Chisholm became the first Black woman elected to the United States Congress. In 1972 she launched a campaign for the Democratic presidential nomination, breaking another political barrier.

MORE →
BHP gathered finds from its connected research sources. Showing the 4 strongest Black History matches.
← BACK TO RESULTS
Wikipedia

Kidney failure

Kidney failure
Other namesRenal failure, end-stage renal disease (ESRD), stage 5 chronic kidney disease[1]
A hemodialysis machine which is used to replace the function of the kidneys
SpecialtyNephrology
SymptomsLeg swelling, feeling tired, reduced urination, foamy urine, loss of appetite, confusion[2]
ComplicationsAcute: Uremia, high blood potassium, volume overload[3]
Chronic: Heart disease, high blood pressure, anemia[4][5]
TypesAcute kidney failure, chronic kidney failure[6]
CausesAcute: [6]
Chronic: [6]
Diagnostic methodAcute:
Chronic:
TreatmentAcute: Depends on the cause[7]
Chronic: Hemodialysis, peritoneal dialysis, kidney transplant[2]
FrequencyAcute: 3 per 1,000 per year[8]
Chronic: 1 per 1,000 (US)[1]

Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels.[2] Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.[6] Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion.[2] Complications of acute and chronic failure include uremia, hyperkalemia, and volume overload.[3] Complications of chronic failure also include heart disease, high blood pressure, and anaemia.[4][5]

Causes of acute kidney failure include low blood pressure, blockage of the urinary tract, certain medications, muscle breakdown, and hemolytic uremic syndrome.[6] Causes of chronic kidney failure include diabetes, high blood pressure, nephrotic syndrome, and polycystic kidney disease.[6] Diagnosis of acute failure is often based on a combination of factors such as decreased urine production or increased serum creatinine.[3] Diagnosis of chronic failure is based on a glomerular filtration rate (GFR) of less than 15 or the need for renal replacement therapy.[1] It is also equivalent to stage 5 chronic kidney disease.[1]

Treatment of acute failure depends on the underlying cause.[7] Treatment of chronic failure may include hemodialysis, peritoneal dialysis, or a kidney transplant.[2] Hemodialysis uses a machine to filter the blood outside the body.[2] In peritoneal dialysis specific fluid is placed into the abdominal cavity and then drained, with this process being repeated multiple times per day.[2] Kidney transplantation involves surgically placing a kidney from someone else and then taking immunosuppressant medication to prevent rejection.[2] Other recommended measures for chronic disease include staying active and specific dietary changes.[2] Depression is also common among patients with kidney failure, and is associated with poor outcomes including higher risk of kidney function decline, hospitalization, and death. A recent PCORI-funded study of patients with kidney failure receiving outpatient hemodialysis found similar effectiveness between nonpharmacological and pharmacological treatments for depression.[9]

In the United States, acute failure affects about 3 per 1,000 people a year.[8] Chronic failure affects about 1 in 1,000 people with 3 per 10,000 people newly developing the condition each year.[1][10] In Canada, the lifetime risk of kidney failure or end-stage renal disease (ESRD) was estimated to be 2.66% for men and 1.76% for women.[11] Acute failure is often reversible while chronic failure often is not.[6] With appropriate treatment many with chronic disease can continue working.[2]

Classification

[edit]

Kidney failure can be divided into two categories: acute kidney failure or chronic kidney failure. The type of renal failure is differentiated by the trend in the serum creatinine; other factors that may help differentiate acute kidney failure from chronic kidney failure include anemia and the kidney size on sonography as chronic kidney disease generally leads to anemia and small kidney size.[12]

Acute kidney failure

[edit]

Acute kidney injury (AKI), previously called acute renal failure (ARF),[13][14] is a rapidly progressive loss of renal function,[15] generally characterized by oliguria (decreased urine production, quantified as less than 400 mL per day in adults,[16] less than 0.5 mL/kg/h in children or less than 1 mL/kg/h in infants); and fluid and electrolyte imbalance. AKI can result from a variety of causes, generally classified as prerenal, intrinsic, and postrenal. Many people diagnosed with paraquat intoxication experience AKI, sometimes requiring hemodialysis.[17]

Chronic kidney failure

[edit]
Illustration of a kidney from a person with chronic renal failure

Chronic kidney disease (CKD) can also develop slowly and, initially, show few symptoms.[18] CKD can be the long term consequence of irreversible acute disease or part of a disease progression.[19][20] CKD is divided into 5 different stages (1–5) according to the estimated glomerular filtration rate (eGFR). In CKD1, eGFR is normal and in CKD5 eGFR has decreased to less than 15 ml/min.[21]

Acute-on-chronic kidney failure

[edit]

Acute kidney injuries can be present on top of chronic kidney disease, a condition called acute-on-chronic kidney failure (AoCRF). The acute part of AoCRF may be reversible, and the goal of treatment, as with AKI, is to return the person to baseline kidney function, typically measured by serum creatinine. Like AKI, AoCRF can be difficult to distinguish from chronic kidney disease if the person has not been monitored by a physician and no baseline (i.e., past) blood work is available for comparison.[22]

Signs and symptoms

[edit]

Symptoms can vary from person to person. Someone in early stage kidney disease may not feel sick or notice symptoms as they occur. When the kidneys fail to filter properly, waste accumulates in the blood and the body, a condition called azotemia. Very low levels of azotemia may produce few, if any, symptoms. If the disease progresses, symptoms become noticeable (if the failure is of sufficient degree to cause symptoms). Kidney failure accompanied by noticeable symptoms is termed uraemia.[23]

Symptoms of kidney failure include the following:[23][24][25][26]

  • High levels of urea in the blood, which can result in:
    • Vomiting or diarrhea (or both) that may lead to dehydration
    • Nausea
    • Weight loss
    • Nocturnal urination (nocturia)
    • More frequent urination, or in greater amounts than usual, with pale urine
    • Less frequent urination, or in smaller amounts than usual, with dark coloured urine
    • Blood in the urine
    • Pressure, or difficulty urinating
    • Unusual amounts of urination, usually in large quantities
  • A buildup of phosphates in the blood that diseased kidneys cannot filter out may cause:
  • A buildup of potassium in the blood that diseased kidneys cannot filter out (called hyperkalemia) may cause:
    • Abnormal heart rhythms
    • Muscle paralysis[27]
  • Failure of kidneys to remove excess fluid may cause:
    • Swelling of the hands, legs, ankles, feet, or face
    • Shortness of breath due to extra fluid on the lungs (may also be caused by anemia)
  • Polycystic kidney disease, which causes large, fluid-filled cysts on the kidneys and sometimes the liver, can cause:
    • Pain in the back or side
  • Healthy kidneys produce the hormone erythropoietin that stimulates the bone marrow to make oxygen-carrying red blood cells. As the kidneys fail, they produce less erythropoietin, resulting in decreased production of red blood cells to replace the natural breakdown of old red blood cells. As a result, the blood carries less hemoglobin, a condition known as anemia. This can result in:
    • Feeling tired or weak
    • Memory problems
    • Difficulty concentrating
    • Dizziness
    • Low blood pressure
  • Normally proteins are too large to pass through the kidneys. However they are able to pass through when the glomeruli are damaged. This does not cause symptoms until extensive kidney damage has occurred,[28] after which symptoms include:
    • Foamy or bubbly urine
    • Swelling in the hands, feet, abdomen, and face
  • Other symptoms include:
    • Appetite loss, which may include a bad taste in the mouth
    • Difficulty sleeping
    • Darkening of the skin
    • Excess protein in the blood
    • With high doses of penicillin, people with kidney failure may experience seizures[29]

Causes

[edit]

Acute kidney injury

[edit]

Acute kidney injury (previously known as acute renal failure) – or AKI – usually occurs when the blood supply to the kidneys is suddenly interrupted or when the kidneys become overloaded with toxins. Causes of acute kidney injury include accidents, injuries, or complications from surgeries in which the kidneys are deprived of normal blood flow for extended periods of time. Heart-bypass surgery is an example of one such procedure.[30][31]

Drug overdoses, accidental or from chemical overloads of drugs such as antibiotics or chemotherapy, along with bee stings[32] may also cause the onset of acute kidney injury. Unlike chronic kidney disease, however, the kidneys can often recover from acute kidney injury, allowing the person with AKI to resume a normal life. People with acute kidney injury require supportive treatment until their kidneys recover function, and they often remain at increased risk of developing future kidney failure.[33]

Among the accidental causes of renal failure is the crush syndrome, when large amounts of toxins are suddenly released in the blood circulation after a long compressed limb is suddenly relieved from the pressure obstructing the blood flow through its tissues, causing ischemia.[34] The resulting overload can lead to the clogging and the destruction of the kidneys. It is a reperfusion injury that appears after the release of the crushing pressure.[35] The mechanism is believed to be the release into the bloodstream of muscle breakdown products – notably myoglobin, potassium, and phosphorus – that are the products of rhabdomyolysis (the breakdown of skeletal muscle damaged by ischemic conditions).[36] The specific action on the kidneys is not fully understood, but may be due in part to nephrotoxic metabolites of myoglobin.[37]

Chronic kidney failure

[edit]

Chronic kidney failure has numerous causes. The most common causes of chronic failure are diabetes mellitus and long-term, uncontrolled hypertension.[38] Polycystic kidney disease is another well-known cause of chronic failure. The majority of people affected with polycystic kidney disease have a family history of the disease. Systemic lupus erythematosus (SLE) is also a known cause of chronic kidney failure. Other genetic illnesses cause kidney failure, as well.[citation needed]

Overuse of common drugs such as ibuprofen, and acetaminophen (paracetamol) can also cause chronic kidney failure.[39] Some infectious disease agents, such as hantavirus, can attack the kidneys, causing kidney failure.[40]

Long term lithium treatment is known to cause chronic kidney disease after 10-20 years of treatment in 1-5% of people.[41][42] End stage renal failure due to lithium occurs in 0.53% of people versus 0.2% in the general population.[43][44][45] Dosing lithium more than once per day is associated with more kidney damage.[46] Kidney harm can be mitigated by dosing lithium once per day at night and keeping the dose as low as possible.[47] Dosing lithium once per day allows for long periods where the kidney is exposed to low levels of lithium, which minimizes kidney harm.[45]

Genetic predisposition

[edit]

The APOL1 gene has been proposed as a major genetic risk locus for a spectrum of nondiabetic renal failure in individuals of African origin, these include HIV-associated nephropathy (HIVAN), primary nonmonogenic forms of focal segmental glomerulosclerosis, and hypertension affiliated chronic kidney disease not attributed to other etiologies.[48] Two western African variants in APOL1 have been shown to be associated with end stage kidney disease in African Americans and Hispanic Americans.[49][50]

Diagnostic approach

[edit]

Measurement for CKD

[edit]
Stages of kidney failure

Chronic kidney failure is measured in five stages, which are calculated using the person's GFR, or glomerular filtration rate.

  • Stage 1 CKD is mildly diminished renal function, with few overt symptoms.
  • Stages 2 and 3 need increasing levels of supportive care from their medical providers to slow and treat their renal dysfunction.
  • People with stage 4 and 5 kidney failure usually require preparation towards active treatment in order to survive.
  • Stage 5 CKD is considered a severe illness and requires some form of renal replacement therapy (dialysis) or kidney transplant whenever feasible.[51]
Glomerular filtration rate

A normal GFR varies according to many factors, including sex, age, body size and ethnic background. Renal professionals consider the glomerular filtration rate (GFR) to be the best overall index of kidney function.[52] The National Kidney Foundation offers an easy-to-use on-line GFR calculator[53] for anyone who is interested in knowing their glomerular filtration rate. (A serum creatinine level, a simple blood test, is needed to use the calculator.)

Complications

[edit]

Those with end stage renal failure who undergo haemodialysis have higher risk of spontaneous intra-abdominal bleeding than the general population (21.2%) and non-occlusive mesenteric ischemia (18.1%). Meanwhile, those undergoing peritoneal dialysis have a higher chance of developing peritonitis and gastrointestinal perforation. However, the rate of acute pancreatitis does not differ from the general population.[54]

Treatment

[edit]

Treatment for kidney failure centers on renal replacement therapy, conservative management, and complication control, as no curative options exist for chronic cases.[55][56] It requires multidisciplinary care and patient education for shared decision-making on RRT initiation.[56]

Renal replacement therapy

[edit]

Renal replacement therapy (RRT) modalities include hemodialysis, peritoneal dialysis, and kidney transplantation, selected based on patient lifestyle, vascular access feasibility, and comorbidities.[55][57] Hemodialysis provides extracorporeal filtration in which machines take over the kidney's filtering function, clearing the blood of extra fluid, dissolved substances, and toxins.[58] Peritoneal dialysis offers home-based continuous therapy using the peritoneum.[59] Guideline recommends advance care planning at GFR 20-30 mL/min, noting equivalent survival across modalities when optimized, though hemodialysis risks infection and peritoneal dialysis risks peritonitis.[56][60]

Diet

[edit]

In non-diabetics and people with type 1 diabetes, a low protein diet is found to have a preventive effect on progression of chronic kidney disease. However, this effect does not apply to people with type 2 diabetes.[61] A whole food, plant-based diet may help some people with kidney disease.[62] A high protein diet from either animal or plant sources appears to have negative effects on kidney function at least in the short term.[63]

Slowing progression

[edit]

People who receive earlier referrals to a nephrology specialist, meaning a longer time before they must start dialysis, have a shorter initial hospitalization and reduced risk of death after the start of dialysis.[64] Other methods of reducing disease progression include minimizing exposure to nephrotoxins such as NSAIDs and intravenous contrast.[65]

References

[edit]
  1. ^ a b c d e f Cheung AK (2005). Primer on Kidney Diseases. Elsevier Health Sciences. p. 457. ISBN 1-4160-2312-7.
  2. ^ a b c d e f g h i j "Kidney Failure". National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 11 November 2017.
  3. ^ a b c d Blakeley S (2010). Renal Failure and Replacement Therapies. Springer Science & Business Media. p. 19. ISBN 978-1-84628-937-8.
  4. ^ a b Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC (2012). "Insulin resistance in patients with chronic kidney disease". Journal of Biomedicine & Biotechnology. 2012 691369. doi:10.1155/2012/691369. PMC 3420350. PMID 22919275.
  5. ^ a b "Kidney Failure". MedlinePlus. Retrieved 11 November 2017.
  6. ^ a b c d e f g "What is renal failure?". Johns Hopkins Medicine. Archived from the original on 18 June 2017. Retrieved 18 December 2017.
  7. ^ a b Clatworthy M (2010). Nephrology: Clinical Cases Uncovered. John Wiley & Sons. p. 28. ISBN 978-1-4051-8990-3.
  8. ^ a b Ferri FF (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 37. ISBN 978-0-323-52957-0.
  9. ^ Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, et al. (March 2019). "Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial". Annals of Internal Medicine. 170 (6): 369–379. doi:10.7326/M18-2229. PMID 30802897. S2CID 67876948.
  10. ^ Ferri FF (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 294. ISBN 978-0-323-52957-0.
  11. ^ Turin TC, Tonelli M, Manns BJ, Ahmed SB, Ravani P, James MT, Hemmelgarn BR (September 2012). "Lifetime risk of ESRD". J Am Soc Nephrol. 23 (9): 1569–1578. doi:10.1681/ASN.2012020164. PMC 3431421. PMID 22904351.
  12. ^ niddk.nih.gov, [Anemia in Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/anemia)
  13. ^ Moore EM, Bellomo R, Nichol AD (November 2012). "The meaning of acute kidney injury and its relevance to intensive care and anaesthesia". Anaesthesia and Intensive Care. 40 (6): 929–48. doi:10.1177/0310057X1204000604. PMID 23194202.
  14. ^ Ricci Z, Ronco C (2012). "New insights in acute kidney failure in the critically ill". Swiss Medical Weekly. 142 (3334): w13662. doi:10.4414/smw.2012.13662. PMID 22923149.
  15. ^ "Acute kidney failure". A.D.A.M. Medical Encyclopedia. U.S. National Library of Medicine. 2012. Archived from the original on 17 January 2014. Retrieved 1 January 2013.
  16. ^ Klahr S, Miller SB (March 1998). "Acute oliguria". The New England Journal of Medicine. 338 (10): 671–5. doi:10.1056/NEJM199803053381007. PMID 9486997.
  17. ^ Weng CH, Chen HH, Hu CC, Huang WH, Hsu CW, Fu JF, Lin WR, Wang IK, Yen TH (2017). "Predictors of acute kidney injury after paraquat intoxication". Oncotarget. 8 (31): 51345–51354. doi:10.18632/oncotarget.17975. PMC 5584253. PMID 28881652.
  18. ^ "Chronic kidney disease". A.D.A.M. Medical Encyclopedia. Medline Plus, National Institutes of Health. 2011. Retrieved 1 January 2013.
  19. ^ Bedford M, Farmer C, Levin A, Ali T, Stevens P (2012-04-01). "Acute Kidney Injury and CKD: Chicken or Egg?". American Journal of Kidney Diseases. 59 (4): 485–491. doi:10.1053/j.ajkd.2011.09.010. ISSN 0272-6386. PMID 22444492.
  20. ^ Belayev LY, Palevsky PM (March 2014). "The link between acute kidney injury and chronic kidney disease". Current Opinion in Nephrology and Hypertension. 23 (2): 149–154. doi:10.1097/01.mnh.0000441051.36783.f3. ISSN 1473-6543. PMC 4179244. PMID 24384553.
  21. ^ "Stages of kidney disease". www.kidneyfund.org. 2021-11-22. Retrieved 2023-03-09.
  22. ^ Wong E, Casula A, Hughes R, Cornish R, Tilling K, Selby NM, Medcalf J (2026-01-27). "Distinguishing AKI from CKD: outcomes and characteristics of patients with abnormal serum creatinine and no known baseline". BMC Nephrology. 27 (1): 126. doi:10.1186/s12882-026-04758-8. ISSN 1471-2369. PMC 12918265. PMID 41593551.
  23. ^ a b Grinsted P (2005-03-02). "Kidney failure (renal failure with uremia, or azotaemia)". Netdoctor. Archived from the original on 2015-10-15. Retrieved 2009-05-26.
  24. ^ Stein A (2007-07-01). Understanding Treatment Options For Renal Therapy. Deerfield, Illinois: Baxter International Inc. p. 6. ISBN 978-1-85959-070-6. Archived from the original on 2019-01-30. Retrieved 2010-07-12.
  25. ^ The PD Companion. Deerfield, Illinois: Baxter International Inc. 2008-05-01. pp. 14–15. 08/1046R. Archived from the original on 2010-06-25. Retrieved 2010-07-12.
  26. ^ Amgen Inc. (2009). "10 Symptoms of Kidney Disease". Retrieved 2009-05-26.
  27. ^ "Hyperkalemia". MedicineNet, Inc. 2008-07-03. Retrieved 2009-05-26.
  28. ^ Hebert LA, Charleston J, Miller E (2009). "Proteinuria". Archived from the original on 2011-05-05. Retrieved 2011-03-24.
  29. ^ Katzung BG (2007). Basic and Clinical Pharmacology (10th ed.). New York, NY: McGraw Hill Medical. p. 733. ISBN 978-0-07-145153-6.
  30. ^ Scurt FG, Bose K, Mertens PR, Chatzikyrkou C, Herzog C (2024-06-01). "Cardiac Surgery-Associated Acute Kidney Injury". Kidney360. 5 (6): 909–926. doi:10.34067/KID.0000000000000466. ISSN 2641-7650. PMC 11219121. PMID 38689404.
  31. ^ Harky A, Joshi M, Gupta S, Teoh WY, Gatta F, Snosi M (2020-04-01). "Acute Kidney Injury Associated with Cardiac Surgery: a Comprehensive Literature Review". Brazilian Journal of Cardiovascular Surgery. 35 (2): 211–224. doi:10.21470/1678-9741-2019-0122. ISSN 1678-9741. PMC 7199993. PMID 32369303.
  32. ^ Silva GB, Vasconcelos AG, Rocha AM, Vasconcelos VR, Barros J, Fujishima JS, et al. (June 2017). "Acute kidney injury complicating bee stings - a review". Revista do Instituto de Medicina Tropical de Sao Paulo. 59 e25. doi:10.1590/S1678-9946201759025. PMC 5459532. PMID 28591253.
  33. ^ National Kidney and Urologic Diseases Information Clearinghouse (2012). "The Kidneys and How They Work". National Institute of Diabetes and Digestive and Kidney Diseases. Archived from the original on 2 May 2015. Retrieved 1 January 2013.
  34. ^ Khan S, Neradi D, Unnava N, Jain M, Tripathy SK (2025-04-18). "Pathophysiology and management of crush syndrome: A narrative review". World Journal of Orthopedics. 16 (4) 104489. doi:10.5312/wjo.v16.i4.104489. ISSN 2218-5836. PMC 12019140. PMID 40290606.
  35. ^ Odeh M (1991-05-16). "The role of reperfusion-induced injury in the pathogenesis of the crush syndrome". The New England Journal of Medicine. 324 (20): 1417–1422. doi:10.1056/NEJM199105163242007. ISSN 0028-4793. PMID 2020298.
  36. ^ Gillani S, Cao J, Suzuki T, Hak DJ (June 2012). "The effect of ischemia reperfusion injury on skeletal muscle". Injury. 43 (6): 670–675. doi:10.1016/j.injury.2011.03.008. ISSN 0020-1383. PMID 21481870.
  37. ^ Lovallo E, Koyfman A, Foran M (September 2012). "Crush syndrome". African Journal of Emergency Medicine. 2 (3): 117–123. doi:10.1016/j.afjem.2012.05.005. ISSN 2211-419X. Archived from the original on 2022-08-02.
  38. ^ Kes P, Basić-Jukić N, Ljutić D, Brunetta-Gavranić B (October 2011). "[The role of arterial hypertension in development of chronic renal failure]" [The role of arterial hypertension in the development of chronic renal failure] (PDF). Acta Medica Croatica (in Croatian). 65 (Suppl 3): 78–84. PMID 23120821. Archived from the original (PDF) on 2013-07-19.
  39. ^ Perneger TV, Whelton PK, Klag MJ (December 1994). "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs". The New England Journal of Medicine. 331 (25): 1675–9. doi:10.1056/NEJM199412223312502. PMID 7969358.
  40. ^ Appel GB, Mustonen J (2012). "Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)". UpToDate. Retrieved 1 January 2013.
  41. ^ Malhi GS, Tanious M, Das P, Berk M (2012-03-01). "The science and practice of lithium therapy". Australian & New Zealand Journal of Psychiatry. 46 (3): 192–211. doi:10.1177/0004867412437346. ISSN 0004-8674. PMID 22391277.
  42. ^ Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, Lewitka U, Licht RW, Manchia M, Müller-Oerlinghausen B, Nielsen RE, Selo M, Simhandl C, Baldessarini RJ, for the International Group for Studies of Lithium (IGSLi) (2019-07-22). "Clinical use of lithium salts: guide for users and prescribers". International Journal of Bipolar Disorders. 7 (1): 16. doi:10.1186/s40345-019-0151-2. ISSN 2194-7511. PMC 6643006. PMID 31328245.
  43. ^ Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H, Mignon F, Grünfeld JP (Aug 2003). "Lithium-induced nephropathy: Rate of progression and prognostic factors". Kidney International. 64 (2): 585–592. doi:10.1046/j.1523-1755.2003.00096.x. ISSN 0085-2538. PMID 12846754.
  44. ^ Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, Calkin CV, Chillotti C, Hidalgo-Mazzei D, Manchia M, Müller-Oerlinghausen B, Murru A, Perugi G, Pinna M, Quaranta G (2017-08-01). "Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters". International Journal of Bipolar Disorders. 5 (1): 27. doi:10.1186/s40345-017-0096-2. ISSN 2194-7511. PMC 5537163. PMID 28480485.
  45. ^ a b Barroilhet SA, Ghaemi SN (2020). "When and how to use lithium". Acta Psychiatrica Scandinavica. 142 (3): 161–172. doi:10.1111/acps.13202. ISSN 1600-0447. PMID 32526812.
  46. ^ Carter L, Zolezzi M, Lewczyk A (2013-10-01). "An Updated Review of the Optimal Lithium Dosage Regimen for Renal Protection". The Canadian Journal of Psychiatry. 58 (10): 595–600. doi:10.1177/070674371305801009. ISSN 0706-7437. PMID 24165107.
  47. ^ MD CA (2026-01-19). "6 Ways to Protect the Kidneys While Prescribing Lithium | Psychiatric Times". www.psychiatrictimes.com. Retrieved 2026-01-19.
  48. ^ Bostrom MA, Freedman BI (June 2010). "The spectrum of MYH9-associated nephropathy". Clinical Journal of the American Society of Nephrology. 5 (6): 1107–13. doi:10.2215/CJN.08721209. PMC 4890964. PMID 20299374.
  49. ^ Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. (August 2010). "Association of trypanolytic ApoL1 variants with kidney disease in African Americans". Science. 329 (5993): 841–5. Bibcode:2010Sci...329..841G. doi:10.1126/science.1193032. PMC 2980843. PMID 20647424.
  50. ^ Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. (September 2010). "Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene". Human Genetics. 128 (3): 345–50. doi:10.1007/s00439-010-0861-0. PMC 2921485. PMID 20635188.
  51. ^ Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) Conference](https://pmc.ncbi.nlm.nih.gov/articles/PMC2390948/)
  52. ^ Fadem, Stephen Z., M.D., FACP, FASN. Calculators for HealthCare Professionals. National Kidney Foundation. 13 Oct 2008 Archived 27 July 2014 at the Wayback Machine
  53. ^ "GFR calculator". Kidney.org. Archived from the original on 2014-07-27. Retrieved 2011-09-25.
  54. ^ Tonolini M, Ierardi AM, Carrafiello G (December 2015). "Letter to the editor: spontaneous renal haemorrhage in end-stage renal disease". Insights into Imaging. 6 (6): 693–695. doi:10.1007/s13244-015-0439-4. PMC 4656237. PMID 26472545.
  55. ^ a b Rout P, Aslam A (2025), "End-Stage Renal Disease", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29763036, retrieved 2025-12-10
  56. ^ a b c Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, Herrington WG, Hill G, Inker LA, Kazancıoğlu R, Lamb E, Lin P, Madero M, McIntyre N, Morrow K (2024-04-01). "KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease". Kidney International. 105 (4): S117–S314. doi:10.1016/j.kint.2023.10.018. ISSN 0085-2538. PMID 38490803.
  57. ^ Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, Herrington WG, Hill G, Inker LA, Kazancıoğlu R, Lamb E, Lin P, Madero M, McIntyre N, Morrow K (2024-04-01). "Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns". Kidney International. 105 (4): 684–701. doi:10.1016/j.kint.2023.10.016. ISSN 0085-2538. PMID 38519239.
  58. ^ Murdeshwar HN, Agarwal A, Anjum F (2025), "Hemodialysis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 33085443, retrieved 2025-12-10
  59. ^ "Peritoneal Dialysis - NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 2025-12-10.
  60. ^ Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V (2020-05-14). "Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress". Biomolecules. 10 (5): 768. doi:10.3390/biom10050768. ISSN 2218-273X. PMC 7277773. PMID 32423139.
  61. ^ Rughooputh MS, Zeng R, Yao Y (28 December 2015). "Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate". PLOS ONE. 10 (12) e0145505. Bibcode:2015PLoSO..1045505R. doi:10.1371/journal.pone.0145505. PMC 4692386. PMID 26710078.
  62. ^ Chauveau P, Combe C, Fouque D, Aparicio M (November 2013). "Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases". Journal of Renal Nutrition. 23 (6): 399–405. doi:10.1053/j.jrn.2013.08.004. PMID 24070587.
  63. ^ Bernstein AM, Treyzon L, Li Z (April 2007). "Are high-protein, vegetable-based diets safe for kidney function? A review of the literature". Journal of the American Dietetic Association. 107 (4): 644–50. doi:10.1016/j.jada.2007.01.002. PMID 17383270. S2CID 39551628.
  64. ^ Smart NA, Dieberg G, Ladhani M, Titus T (June 2014). "Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease". The Cochrane Database of Systematic Reviews (6) CD007333. doi:10.1002/14651858.CD007333.pub2. PMID 24938824.
  65. ^ Dirkx TC, Woodell T, Watnick S (2017). Papadakis MA, McPhee SJ, Rabow MW (eds.). Current Medical Diagnosis & Treatment 2018. New York, NY: McGraw-Hill Education.
[edit]

Source: Wikipedia. Article content is retrieved live through the MediaWiki API.

Wikipedia

Kidney failure

Kidney failure, also known as renal failure or end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels. Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible. Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications of acute and chronic failure include uremia, hyperkalemia, and volume overload. Complications of chronic failure also include heart disease, high blood pressure, and anaemia. Causes of acute kidney failure include low blood pressure, blockage of the urinary tract, certain medications, muscle breakdown, and hemolytic uremic syndrome. Causes of chronic kidney failure include diabetes, high blood pressure, nephrotic syndrome, and polycystic kidney disease. Diagnosis of acute failure is often based on a combination of factors such as decreased urine production or increased serum creatinine. Diagnosis of chronic failure is based on a glomerular filtration rate (GFR) of less than 15 or the need for renal replacement therapy. It is also equivalent to stage 5 chronic kidney disease. Treatment of acute failure depends on the underlying cause. Treatment of chronic failure may include hemodialysis, peritoneal dialysis, or a kidney transplant. Hemodialysis uses a machine to filter the blood outside the body. In peritoneal dialysis specific fluid is placed into the abdominal cavity and then drained, with this process being repeated multiple times per day. Kidney transplantation involves surgically placing a kidney from someone else and then taking immunosuppressant medication to prevent rejection. Other recommended measures for chronic disease include staying active and specific dietary changes. Depression is also common among patients with kidney failure, and is associated with poor outcomes including higher risk of kidney function decline, hospitalization, and death. A recent PCORI-funded study of patients with kidney failure receiving outpatient hemodialysis found similar effectiveness between nonpharmacological and pharmacological treatments for depression. In the United States, acute failure affects about 3 per 1,000 people a year. Chronic failure affects about 1 in 1,000 people with 3 per 10,000 people newly developing the condition each year. In Canada, the lifetime risk of kidney failure or end-stage renal disease (ESRD) was estimated to be 2.66% for men and 1.76% for women. Acute failure is often reversible while chronic failure often is not. With appropriate treatment many with chronic disease can continue working.

MORE →
Wikipedia

Kidney

In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation. They are located on the left and right in the retroperitoneal space, and in adult humans are about 12 centimetres (4+1⁄2 inches) in length. They receive blood from the paired renal arteries; blood exits into the paired renal veins. Each kidney is attached to a ureter, a tube that carries excreted urine to the bladder. The kidney participates in the control of the volume of various body fluids, fluid osmolality, acid–base balance, various electrolyte concentrations, and removal of toxins. Filtration occurs in the glomerulus: one-fifth of the blood volume that enters the kidneys is filtered. Examples of substances reabsorbed are solute-free water, sodium, bicarbonate, glucose, and amino acids. Examples of substances secreted are hydrogen, ammonium, potassium and uric acid. The nephron is the structural and functional unit of the kidney. Each adult human kidney contains around 1 million nephrons, while a mouse kidney contains only about 12,500 nephrons. The kidneys also carry out functions independent of the nephrons. For example, they convert a precursor of vitamin D to its active form, calcitriol; and synthesize the hormones erythropoietin and renin. Chronic kidney disease (CKD) has been recognized as a leading public health problem worldwide. The global estimated prevalence of CKD is 13.4%, and patients with kidney failure needing renal replacement therapy are estimated between 5 and 7 million. Procedures used in the management of kidney disease include chemical and microscopic examination of the urine (urinalysis), measurement of kidney function by calculating the estimated glomerular filtration rate (eGFR) using the serum creatinine; and kidney biopsy and CT scan to evaluate for abnormal anatomy. Dialysis and kidney transplantation are used to treat kidney failure; one (or both sequentially) of these are almost always used when renal function drops below 15%. Nephrectomy is frequently used to cure renal cell carcinoma. Renal physiology is the study of kidney function. Nephrology is the medical specialty that addresses diseases of kidney function: these include CKD, nephritic and nephrotic syndromes, acute kidney injury, and pyelonephritis. Urology addresses diseases of kidney (and urinary tract) anatomy: these include cancer, renal cysts, kidney stones and ureteral stones, and urinary tract obstruction. The word "renal" is an adjective meaning "relating to the kidneys", and its roots are French or late Latin. Whereas according to some opinions, "renal" should be replaced with "kidney" in scientific writings such as "kidney artery", other experts have advocated preserving the use of "renal" as appropriate including in "renal artery".

MORE →
Wikipedia

Kidney dialysis

Kidney dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. Along with kidney transplantation, it is a type of renal replacement therapy. Dialysis may need to be initiated when there is a sudden rapid loss of kidney function, known as acute kidney injury (previously called acute renal failure), or when a gradual decline in kidney function, chronic kidney failure, reaches stage 5. Stage 5 chronic renal failure is reached when the glomerular filtration rate is less than 15% of the normal, creatinine clearance is less than 10 mL per minute, and uremia is present. Dialysis is used as a temporary measure in cases of acute kidney injury or for those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. In West European countries, Australia, Canada, the United Kingdom, and the United States, dialysis is paid for by the government for those who are eligible. The first successful dialysis was performed in 1943.

MORE →
Wikipedia

Chronic kidney disease

Chronic kidney disease (CKD) is a type of long-term kidney disease, defined by the sustained presence of abnormal kidney function and/or abnormal kidney structure. To meet the criteria for CKD, the abnormalities must be present for at least three months. Early in the course of CKD, patients are usually asymptomatic, but can be diagnosed via proteinuria. At later stages, the symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications can relate to hormonal dysfunction of the kidneys and include high blood pressure (often related to activation of the renin–angiotensin system), insulin resistance, bone disease, and anemia. Additionally CKD patients have markedly increased cardiovascular complications with increased risks of death and hospitalization. CKD can lead to end-stage kidney failure requiring kidney dialysis or kidney transplantation. Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of chronic kidney disease. Diagnosis is by blood tests to measure the estimated glomerular filtration rate (eGFR), and a urine test to measure albumin. Ultrasound or kidney biopsy may be performed to determine the underlying cause. Several severity-based staging systems are in use. Testing people with risk factors (case-finding) is recommended. Initial treatments may include medications to lower blood pressure, blood sugar, and cholesterol. Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin II receptor antagonists (ARBs) are generally first-line agents for blood pressure control, as they slow progression of the kidney disease and the risk of heart disease. Loop diuretics may be used to control edema and, if needed, to further lower blood pressure. NSAIDs should be avoided. Other recommended measures include staying active, and "to adopt healthy and diverse diets with a higher consumption of plant-based foods compared to animal-based foods and a lower consumption of ultraprocessed foods." Plant-based diets are feasible and are associated with improved intermediate outcomes and biomarkers. An example of a general, healthy diet, suitable for people with CKD who do not require restrictions, is the Canada Food Guide Diet. People with CKD who require dietary restrictions or who have other specific nutritional problems should be referred to a dietitian. Treatments for anemia and bone disease may also be required. Severe disease requires hemodialysis, peritoneal dialysis, or a kidney transplant for survival. 8-16% of the world's population has chronic kidney disease. Other estimates have chronic kidney disease affecting 753 million people globally in 2016 (417 million females and 336 million males). In 2015, it caused 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

MORE →
TOPIC OF THE DAY

Greenwood / Black Wall Street

Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.

MORE →
TRIVIA QUESTION OF THE DAY

Which Supreme Court case ruled state-sponsored public-school segregation unconstitutional?

Brown v. Board of Education in 1954.